Nuskin Enterprises Inc: (NYSE: NUS)

$59.94

-0.92 (-1.51%)

Volume 127,773

May 23 09:43 AM ET

Zacks Rank: 1-Strong Buy

#1
 
 
 
 

Balance Sheet

Get Balance Sheet for:

Annual Balance Sheet

Fiscal Year End for NU SKIN ENTERP falls in the month of December.

All items in Millions except Per Share data.

12/31/12 12/31/11 12/31/10 12/31/09 12/31/08
Assets          
Cash & Equivalents 333 291 230 158 115
Receivables 37 32 26 23 16
Notes Receivable 0 0 0 0 0
Inventories 136 112 114 106 114
Other Current Assets 93 96 52 52 45
Total Current Assets 599 530 423 338 290
Net Property & Equipment 230 150 134 79 82
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 205 196 191 194 200
Deposits & Other Assets 119 116 145 137 137
Total Assets 1,153 991 892 748 710
Liabilities & Shareholders Equity 12/31/12 12/31/11 12/31/10 12/31/09 12/31/08
Notes Payable 0 0 0 0 0
Accounts Payable 48 32 25 25 20
Current Portion Long-Term Debt 39 29 28 35 30
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 233 180 146 125 116
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 17 0 0
Total Current Liabilities 320 241 216 185 166
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 155 108 133 121 159
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 87 68 72 66 68
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 562 417 421 373 394
Shareholders Equity 12/31/12 12/31/11 12/31/10 12/31/09 12/31/08
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 317 292 257 232 219
Retained Earnings 1,040 867 750 645 584
Other Equity -52 -63 -59 -68 -70
Treasury Stock 715 522 477 434 417
Total Shareholder's Equity 591 574 471 376 316
Total Liabilities & Shareholder's Equity 1,153 991 892 748 710
Total Common Equity 591 574 471 376 316
Shares Outstanding 58.60 62.10 62.10 62.70 64.50
Book Value Per Share 10.08 9.25 7.59 5.99 4.90

Quarterly Balance Sheet

Fiscal Year End for NU SKIN ENTERP falls in the month of December.

All items in Millions except Per Share data.

03/31/13 12/31/12 09/30/12 06/30/12 03/31/12
Assets          
Cash & Equivalents 334 333 338 385 290
Receivables 44 37 42 44 38
Notes Receivable 0 0 0 0 0
Inventories 149 136 137 125 121
Other Current Assets 92 93 88 91 102
Total Current Assets 619 599 605 645 551
Net Property & Equipment 264 230 195 170 156
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 202 205 189 192 193
Deposits & Other Assets 122 119 127 129 129
Total Assets 1,208 1,153 1,116 1,135 1,028
Liabilities & Shareholders Equity 03/31/13 12/31/12 09/30/12 06/30/12 03/31/12
Notes Payable 0 0 0 0 0
Accounts Payable 52 48 41 45 42
Current Portion Long-Term Debt 57 39 29 28 28
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 251 233 231 226 169
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 359 320 301 299 239
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 139 155 183 191 96
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 93 87 82 78 72
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 591 562 565 568 407
Shareholders Equity 03/31/13 12/31/12 09/30/12 06/30/12 03/31/12
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 320 317 311 305 297
Retained Earnings 1,077 1,040 992 950 902
Other Equity -55 -52 -58 -59 -55
Treasury Stock 724 715 695 629 523
Total Shareholder's Equity 617 591 550 567 622
Total Liabilities & Shareholder's Equity 1,208 1,153 1,116 1,135 1,028
Total Common Equity 617 591 550 567 622
Shares Outstanding 58.30 58.60 59.80 63.10 63.10
Book Value Per Share 10.58 10.08 9.20 8.99 9.85

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.